NON-PROSECUTION AGREEMENT BETWEEN JAZZ PHARMACEUTICALS, INC. AND THE U.S. ATTORNEY’S OFFICE FOR THE EASTERN DISTRICT OF NEW YORKNon-Prosecution Agreement • July 18th, 2007 • Jazz Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledJuly 18th, 2007 Company IndustryJAZZ PHARMACEUTICALS, INC. (“JPI”), by its undersigned attorneys, pursuant to authority granted by its Board of Directors, and the UNITED STATES ATTORNEY’S OFFICE FOR THE EASTERN DISTRICT OF NEW YORK (the “Office”), hereby enter into this Agreement (the “Agreement”).
SETTLEMENT AGREEMENTSettlement Agreement • July 18th, 2007 • Jazz Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledJuly 18th, 2007 Company IndustryThis Settlement Agreement (the “Agreement”) is entered into among the United States of America, acting through its Department of Justice and the United States Attorney’s Office for the Eastern District of New York, the Office of Inspector General of the Department of Health and Human Services (“HHS-OIG”), the United States Office of Personnel Management (“OPM”), and the United States Department of Defense TRICARE Management Activity (“TMA”) (collectively the “United States”); Jazz Pharmaceuticals, Inc. (“JPI”) and Orphan Medical, Inc. (“Orphan”) (JPI and Orphan are collectively referred to as “Defendants”); and Shelley Lauterbach (the “Relator”); through their authorized representatives. Collectively, all of the above will be referred to as “the Parties.”
CORPORATE INTEGRITY AGREEMENT BETWEEN THE OFFICE OF INSPECTOR GENERAL OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES AND JAZZ PHARMACEUTICALS, INC.Corporate Integrity Agreement • July 18th, 2007 • Jazz Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledJuly 18th, 2007 Company Industry
UNITED STATES OF AMERICA PLEA AGREEMENT —against— 07 CR 531 (ENV) ORPHAN MEDICAL, INC., Defendant. - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -XJazz Pharmaceuticals Inc • July 18th, 2007 • Pharmaceutical preparations
Company FiledJuly 18th, 2007 IndustryPursuant to Rule 11 of the Federal Rules of Criminal Procedure, the United States Attorney’s Office for the Eastern District of New York (the “Office”) and ORPHAN MEDICAL, INC. (the “defendant”) agree to the following: